Eon Labs Pays U.S. $3.5 Million to Settle Allegations of Submitting False Claims to Medicaid

Eon Labs Inc. has agreed to pay the United States $3.5 million to resolve False Claims Act allegations relating to the company’s drug Nitroglycerin Sustained Release (SR) capsules.